HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ming Guo Selected Research

15-keto-13,14-dihydroprostaglandin E2

2/2021Combination of Panax notoginseng saponins and aspirin potentiates platelet inhibition with alleviated gastric injury via modulating arachidonic acid metabolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ming Guo Research Topics

Disease

42Neoplasms (Cancer)
08/2022 - 07/2002
15Infections
12/2022 - 11/2012
10Carcinoma (Carcinomatosis)
10/2021 - 02/2007
9Inflammation (Inflammations)
01/2022 - 10/2016
8Tuberculosis (Tuberculoses)
09/2019 - 06/2002
7Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 02/2012
7Coronary Artery Disease (Coronary Atherosclerosis)
01/2020 - 01/2016
7Parkinson Disease (Parkinson's Disease)
12/2016 - 06/2006
6Lung Neoplasms (Lung Cancer)
01/2022 - 11/2008
6Uterine Cervical Dysplasia
02/2011 - 12/2004
4Insulin Resistance
01/2022 - 12/2009
4Neoplasm Metastasis (Metastasis)
03/2021 - 02/2011
4Myocardial Infarction
02/2021 - 03/2015
4Coronary Disease (Coronary Heart Disease)
02/2021 - 01/2016
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 01/2019
4Squamous Cell Carcinoma of Head and Neck
01/2021 - 08/2002
4Anhedonia
01/2021 - 04/2011
4Muscular Diseases (Myopathy)
05/2020 - 01/2017
4Prostatic Neoplasms (Prostate Cancer)
01/2018 - 10/2009
4Type 2 Diabetes Mellitus (MODY)
08/2015 - 12/2009
4Atypical Squamous Cells of the Cervix
02/2015 - 08/2008
3COVID-19
09/2021 - 01/2020
3Head and Neck Neoplasms (Head and Neck Cancer)
01/2021 - 07/2002
3Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia
05/2020 - 01/2017
3Neurodegenerative Diseases (Neurodegenerative Disease)
05/2020 - 04/2014
3Frontotemporal Dementia (Semantic Dementia)
05/2020 - 01/2017
3Atherosclerosis
04/2020 - 01/2016
3Virus Diseases (Viral Diseases)
03/2020 - 01/2013
3Fibrosis (Cirrhosis)
02/2020 - 03/2015
3Reperfusion Injury
01/2020 - 01/2016
3Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2017 - 10/2009
2Disease Resistance
08/2022 - 01/2021
2Pruritus (Itching)
01/2022 - 01/2021
2Body Weight (Weight, Body)
01/2022 - 01/2004
2Multiple Sclerosis
01/2022 - 10/2016
2Acute Coronary Syndrome
01/2022 - 05/2021
2Necrosis
12/2021 - 01/2021
2Bites and Stings (Sting)
12/2021 - 01/2018
2Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
04/2021 - 01/2021
2Hypoxia (Hypoxemia)
03/2021 - 07/2004
2Heart Failure
01/2021 - 01/2021
2Autoimmune Diseases (Autoimmune Disease)
01/2021 - 10/2016
2Hepatocellular Carcinoma (Hepatoma)
01/2020 - 04/2019
2Mitochondrial Diseases (Mitochondrial Disease)
12/2019 - 01/2017
2Liver Neoplasms (Liver Cancer)
04/2019 - 01/2018

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
01/2022 - 09/2003
12Pharmaceutical PreparationsIBA
08/2022 - 06/2002
9DNA (Deoxyribonucleic Acid)IBA
01/2019 - 02/2007
8Biomarkers (Surrogate Marker)IBA
08/2022 - 07/2011
8CytokinesIBA
01/2022 - 03/2014
8VaccinesIBA
02/2021 - 12/2014
6AntigensIBA
01/2018 - 03/2007
5Messenger RNA (mRNA)IBA
08/2022 - 01/2009
5Phosphotransferases (Kinase)IBA
04/2014 - 06/2006
5Niacinamide (Nicotinamide)FDA LinkGeneric
12/2013 - 12/2009
4MicroRNAs (MicroRNA)IBA
04/2022 - 11/2008
4SaponinsIBA
02/2021 - 01/2018
3Interleukin-2 (IL2)IBA
12/2022 - 07/2002
3LipidsIBA
01/2022 - 01/2014
3Interleukin-17 (Interleukin 17)IBA
01/2022 - 02/2012
3Blood Glucose (Blood Sugar)IBA
01/2022 - 01/2012
3Glucose (Dextrose)FDA LinkGeneric
01/2022 - 05/2010
3Anaplastic Lymphoma KinaseIBA
03/2021 - 10/2020
3Cisplatin (Platino)FDA LinkGeneric
01/2021 - 07/2002
3Therapeutic UsesIBA
01/2021 - 07/2011
3Valosin Containing ProteinIBA
05/2020 - 01/2017
3Peptides (Polypeptides)IBA
09/2019 - 10/2003
3Formaldehyde (Formol)FDA Link
01/2019 - 02/2007
3ParaffinIBA
01/2019 - 02/2007
3SmokeIBA
01/2018 - 07/2011
3Estrogen ReceptorsIBA
01/2013 - 01/2009
2Anti-Bacterial Agents (Antibiotics)IBA
12/2022 - 02/2012
2Circular RNAIBA
08/2022 - 01/2022
2Immunoglobulin G (IgG)IBA
01/2022 - 01/2021
2EnzymesIBA
01/2022 - 04/2021
2Insulin (Novolin)FDA Link
01/2022 - 01/2012
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
12/2021 - 01/2018
2Inosine Triphosphate (ITP)IBA
04/2021 - 01/2021
2Reactive Oxygen Species (Oxygen Radicals)IBA
03/2021 - 01/2021
2Carboplatin (JM8)FDA LinkGeneric
01/2021 - 01/2021
2AntibodiesIBA
01/2021 - 01/2019
2Sucrose (Saccharose)IBA
01/2021 - 04/2011
2baicalinIBA
11/2020 - 03/2014
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2020 - 01/2018
2indoleIBA
09/2020 - 01/2020
2Surface-Active Agents (Surfactants)IBA
03/2020 - 01/2020
2Capsules (Microcapsules)IBA
01/2020 - 01/2016
2Carrier Proteins (Binding Protein)IBA
10/2019 - 08/2015
2PyrazinamideFDA LinkGeneric
09/2019 - 06/2002

Therapy/Procedure

20Therapeutics
01/2022 - 08/2002
6Drug Therapy (Chemotherapy)
01/2021 - 07/2002
6Radiotherapy
01/2021 - 12/2007
5Percutaneous Coronary Intervention
05/2021 - 01/2016
4Immunotherapy
12/2022 - 01/2020
3Oral Administration
08/2022 - 04/2010
3Lasers (Laser)
03/2021 - 08/2020
2Stents
01/2022 - 05/2020
2Aftercare (After-Treatment)
04/2021 - 02/2015
2Photothermal Therapy
03/2021 - 12/2020
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2020 - 01/2018